呼吸类药物

Search documents
持续优化营商环境 200余家外商投资企业扎根青岛高新区
Sou Hu Cai Jing· 2025-05-28 03:30
Core Insights - Qingdao High-tech Zone has attracted 217 foreign-invested enterprises with a total investment of approximately $6.85 billion, indicating a robust foreign investment environment [1][4] - The AstraZeneca inhalation aerosol production base project in Qingdao represents a significant milestone, with a total investment of $750 million and an expected annual production of 54 million respiratory drugs [1][4] - The successful establishment of foreign enterprises is attributed to the optimized business environment and efficient service provided by Qingdao High-tech Zone, enhancing confidence for multinational companies [4] Investment Environment - Qingdao High-tech Zone has implemented a series of policies to improve the business environment, including streamlined approval processes and "one-stop" services for foreign enterprises [4][5] - The zone has hosted thematic salons to facilitate market expansion for foreign enterprises, promoting resource and information flow [4] Company Performance - Ediwos Vacuum Pump Manufacturing (Qingdao) Co., Ltd. has experienced over 30 times growth in the past decade, with total investments reaching 1.1 billion yuan and an annual production capacity of over 30,000 vacuum pumps [5] - Hexagon, the world's largest coordinate measuring machine manufacturer, has invested over 50 million yuan to add two high-end portable precision measuring instrument production lines, further expanding its operations in Qingdao [5][6] Technological Advancements - Hexagon's new pilot demonstration base in advanced manufacturing technology is expected to achieve over 20 million yuan in revenue in 2024, with a 40% reduction in R&D costs due to its proprietary simulation system [6]
阿斯利康落地跑出“高新速度”,青岛打造外资磁吸新高地
Qi Lu Wan Bao Wang· 2025-05-27 09:06
Group 1 - The core project of AstraZeneca's inhalation aerosol production base in Qingdao has a total investment of $750 million and is expected to produce 54 million respiratory drugs annually [1][3] - The successful establishment of the project is attributed to the "high-speed" and "high-temperature" service model of Qingdao High-tech Zone, which resolved over 400 issues in a timely manner [1][3] Group 2 - Qingdao High-tech Zone has optimized its business environment, providing strong confidence and opportunities for multinational companies, as highlighted by AstraZeneca's factory manager [3] - The zone has implemented a "one-stop" service for foreign enterprises, facilitating market expansion and resource information flow through various initiatives [3][4] Group 3 - Foreign enterprises in Qingdao High-tech Zone have seen significant growth, with one company reporting a 30-fold increase in performance over ten years, supported by favorable business conditions [4] - Hexagon, a major foreign investor, has established its Greater China headquarters in the zone and recently invested over $5 million to expand its production capacity [4][5] Group 4 - The High-tech Zone has attracted 217 foreign-invested enterprises with a total investment of approximately $6.85 billion, contributing to an industrial output value of 16.573 billion yuan in 2024 [6] - The zone aims to continuously enhance its business environment and innovation resources to attract more foreign investment and promote high-quality development [6]
236家世界500强企业在山东投资,解码山东外资吸引力
Qi Lu Wan Bao Wang· 2025-05-16 23:32
Group 1 - The core viewpoint of the news is that Shandong province is enhancing cooperation with multinational companies to promote high-level opening-up and economic development [1][2][3] - AstraZeneca has significantly increased its investment in China, establishing a production base for inhalation aerosol in Qingdao, which will meet the demand for respiratory drugs and enhance the influence of the biopharmaceutical industry in the region [1][3] - Shandong has over 19,000 foreign-funded enterprises, including 236 Fortune 500 companies, which have invested in 943 projects, indicating a strong commitment to high-quality development and a favorable business environment [2][3] Group 2 - Foreign-funded enterprises contribute significantly to Shandong's economy, with 2,769 industrial foreign-funded enterprises accounting for 14.2% of the revenue, 22.6% of the profits, and 14.9% of employment in the province [3] - Multinational companies are enhancing the optimization of industrial and supply chains, as seen with Henkel's $100 million investment in a high-end adhesive production base and Komatsu's establishment of a global smart manufacturing base in Jining [3] - Shandong plans to implement customized services for multinational companies, addressing their specific needs to support high-quality development in the province [3]
特写:一场开进跨国公司的新闻发布会
Zhong Guo Xin Wen Wang· 2025-05-16 15:03
Group 1 - The core message of the press conference is to express the intention of collaboration and growth with multinational companies in Shandong, highlighting the investment opportunities in the region [1] - The AstraZeneca inhalation aerosol production base in Qingdao has a total investment of $750 million and will produce 54 million units of respiratory drugs annually [1] - The construction of the AstraZeneca facility was completed in just 12 months, reflecting the company's confidence in the Chinese market and its commitment to long-term investment [2] Group 2 - Shandong province has over 19,000 foreign-funded enterprises, including 236 Fortune 500 companies that have invested in 943 projects [2] - The upcoming sixth summit for multinational company leaders will focus on global industrial transformation, investment trends, and Shandong's advantages in attracting industry [3] - The success of companies like Ediwos Vacuum Pump Manufacturing in Qingdao, which has expanded three times in the past decade and achieved over 30 times growth, demonstrates the confidence in the Chinese market [3]
(投资中国)阿斯利康中国总经理:将持续加码在华投资
Zhong Guo Xin Wen Wang· 2025-04-24 12:22
林骁表示,自1993年进入中国以来,阿斯利康持续推进本土化战略,不断扩大研发、生产、运营布局, 累计在华投资金额超50亿美元。目前,中国已成为阿斯利康全球第二大市场。 中新社青岛4月24日电 (胡耀杰王禹)"中国坚持推动普惠包容的全球化经济、扩大开放以及维护全球产业 链稳定的承诺,为跨国企业在中国及全球市场的发展注入强大信心,提供广阔的发展机遇。"英国制药 企业阿斯利康中国总经理林骁24日在山东青岛接受中新社记者采访时如是说。 当日,阿斯利康青岛吸入气雾剂生产供应基地一期(建筑主体)建成活动在山东青岛举行。作为山东省首 个跨国药企生产制造类项目,该基地总投资7.5亿美元,占地80亩,投产后预计年产呼吸类药物5400万 支。 4月24日,阿斯利康青岛吸入气雾剂生产供应基地一期(建筑主体)建成活动在山东青岛举行。李心怡摄 据介绍,阿斯利康青岛吸入气雾剂生产供应基地项目2024年1月正式开工,8个月完成主体封顶,12个月 完成项目主体竣工。 2025年3月,阿斯利康宣布了25亿美元投资计划,将在北京建立第六个全球战略研发中心。"目前,阿斯 利康在中国研发管线与全球研发管线的同步研发率已达100%,并计划在2030年 ...